Cargando…
LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation
Cancer and chronic infections often increase levels of the bioactive lipid, lysophosphatidic acid (LPA), that we have demonstrated acts as an inhibitory ligand upon binding LPAR5 on CD8 T cells, suppressing cytotoxic activity and tumor control. This study, using human and mouse primary T lymphocytes...
Autores principales: | Kremer, Kimberly N., Buser, Alan, Thumkeo, Dean, Narumiya, Shuh, Jacobelli, Jordan, Pelanda, Roberta, Torres, Raul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169816/ https://www.ncbi.nlm.nih.gov/pubmed/35394866 http://dx.doi.org/10.1073/pnas.2118816119 |
Ejemplares similares
-
LPA(5) Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling
por: Mathew, Divij, et al.
Publicado: (2019) -
Rho signaling research: history, current status and future directions
por: Narumiya, Shuh, et al.
Publicado: (2018) -
An optimized protocol to identify keratinocyte subpopulations in vitro by single-cell RNA sequencing analysis
por: Siriwach, Ratklao, et al.
Publicado: (2022) -
Deficiency of mDia, an Actin Nucleator, Disrupts Integrity of Neuroepithelium and Causes Periventricular Dysplasia
por: Thumkeo, Dean, et al.
Publicado: (2011) -
T cell–intrinsic prostaglandin E(2)-EP2/EP4 signaling is critical in pathogenic T(H)17 cell–driven inflammation
por: Lee, Jinju, et al.
Publicado: (2019)